ORAJEL FOR COLD SORES  SINGLE DOSE- benzalkonium chloride, benzocaine liquid 
Church & Dwight Co., Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Orajel Cold Sore Touch Free, Single Dose

Active ingredients

ACTIVE INGREDIENTS

Benzalkonium chloride, 0.13%

Benzocaine, 5%

Purpose

PURPOSE

Topical Antiseptic

Uses

USES

Warnings

WARNINGS

For external use only. Flammable, keep away from fire or flame.

Methemoglobinemia warning: Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray or blue colored skin (cyanosis), headache, rapid heart beat, shortness of breath, dizziness or lightheadedness, fatigue or lack of energy

Allergy alert: do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other "caine" anesthetics

Do not use

Stop use and ask a dentist or physician if

Ask a physician if

When using this product

You may feel a brief stinging sensation when you apply it.  The sting should go away in a short time.

Keep out of reach of children

KEEP OUT OF REACH OF CHILDREN

In case of overdose, or allergic reaction, get medical help or contact a Poison Control Center right away.

Directions

Directions

• Slide-off to remove the protective blue paper cover and slide it on the other end-opposite the white applicator tip

• Squeeze the vial firmly on the arrow shown on the blue paper cap until you hear it snap

• Hold with the white applicator tip down to allow the medication to saturate the tip

• To minimize pain during application gently touch the site of the cold sore with the saturated applicator tip. Once the area is numb, rub the site of the cold sore and the surrounding area. Rub firmly to allow the treatment to deeply penetrate the skin.

• To treat most cold sores, multiple treatments may be required

• Discard after use

• For best results ensure that lip area is free of lip preparations, lotions, ointments, residual beverages, or cosmetics, including lipstick

Adults and children over 2 years of age: Do not use this more than 3 times per day

Children between 2 year and 12 years of age: Ask a doctor before use. Should be supervised in the use of this product

Children under 2 years of age: Do not use







OTHER INFORMATION

Inactive ingredients

INACTIVE INGREDIENTS

isopropyl alcohol (70% v/v), water

Questions or comments?

Questions or comments call us at 1 800 952 5080 Monday through Friday ET or visit our website at www orajel com

Principal Display Panel

Fast-Acting

Orajel™ Instant Pain Relief

Coldsore

Patented Treatment

Topical Antiseptic/

Topical Anethetic

Contains 4 treatment vials

NET 0.08 FL OZ (2.4mL) Total

OJBC-99881-04.jpg

ORAJEL FOR COLD SORES   SINGLE DOSE
benzalkonium chloride, benzocaine liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10237-756
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.3 mg  in 1 mL
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10237-756-044 in 1 PACKAGE07/01/201209/30/2024
12.4 mL in 1 VIAL, SINGLE-DOSE; Type 0: Not a Combination Product
2NDC:10237-756-032 in 1 PACKAGE07/01/201212/18/2019
21.2 mL in 1 VIAL, SINGLE-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35607/01/201209/30/2024
Labeler - Church & Dwight Co., Inc. (001211952)

Revised: 2/2022
Document Id: d7723392-c3a1-1bb4-e053-2995a90af3d6
Set id: 05efbe22-2fed-42e3-a181-65558805cb2a
Version: 7
Effective Time: 20220207
 
Church & Dwight Co., Inc.